VISTAGEN THERAPEUTICS, INC. Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31)
VISTAGEN THERAPEUTICS, INC. (VTGN) had Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) of $242.27 thousand as of 2011-04-29, per its 10-Q filed 2012-08-14.
Discontinued › Notes
us-gaap:LineOfCreditFacilityAmountOutstanding · last filed 2012-08-14
- 2011-04-29: Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) $242.27K.
| Period end | Line of Credit Facility, Amount Outstanding (Deprecated 2014-01-31) |
|---|---|
| 2011-04-29 | $242.27K 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |